These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2993842)

  • 1. Update: evaluation of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection in health-care personnel--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Sep; 34(38):575-8. PubMed ID: 2993842
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Nov; 34(45):681-6, 691-5. PubMed ID: 2997587
    [No Abstract]   [Full Text] [Related]  

  • 3. Update: evaluation of human T-lymphotropic virus. Type III/lymphadenopathy-associated virus infection in health-care personnel--United States. Centers for Disease Control.
    Conn Med; 1985 Nov; 49(11):772. PubMed ID: 2998701
    [No Abstract]   [Full Text] [Related]  

  • 4. Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Aug; 35(34):540-2, 547-9. PubMed ID: 3018469
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Oct; 105(4):558-9. PubMed ID: 3019202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jun; 35(23):376-8, 383. PubMed ID: 3012309
    [No Abstract]   [Full Text] [Related]  

  • 7. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Apr; 35(14):221-3. PubMed ID: 3007970
    [No Abstract]   [Full Text] [Related]  

  • 9. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody prevalence in U.S. military recruit applicants.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jul; 35(26):421-4. PubMed ID: 3014305
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 May; 35(17):284-7. PubMed ID: 3010070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 13. Update: prospective evaluation of health-care workers exposed via the parenteral or mucous-membrane route to blood or body fluids from patients with acquired immunodeficiency syndrome--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Feb; 34(7):101-3. PubMed ID: 3918247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent transmission of human T-lymphotrophic virus type III/lymphadenopathy-associated virus from a child to a mother providing health care.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Feb; 35(5):76-9. PubMed ID: 3003555
    [No Abstract]   [Full Text] [Related]  

  • 15. Update: acquired immunodeficiency syndrome and human immunodeficiency virus infection among health-care workers.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Apr; 37(15):229-34, 239. PubMed ID: 3127675
    [No Abstract]   [Full Text] [Related]  

  • 16. American Academy of Pediatrics. Committee on School Health, Committee on Infectious Diseases. School attendance of children and adolescents with human T lymphotropic virus III/lymphadenopathy-associated virus infection.
    Pediatrics; 1986 Mar; 77(3):430-2. PubMed ID: 3456556
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
    Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
    Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to a retrovirus etiologically associated with acquired immunodeficiency syndrome (AIDS) in populations with increased incidences of the syndrome.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Jul; 33(27):377-9. PubMed ID: 6330518
    [No Abstract]   [Full Text] [Related]  

  • 19. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Jun; 104(6):824-5. PubMed ID: 3010783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Centers for Disease Control, U.S. Department of Health and Human Services.
    Ann Intern Med; 1986 Aug; 105(2):234-7. PubMed ID: 3014942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.